JVSPAC Acquisition Corp. Unit (JVSA) 10-Q 8 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 08, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	JVSPAC ACQUISITION CORP.
Entity Central Index Key	0001866001
Entity File Number	001-41922
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	D8
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	G/F Hang Tak Building
Entity Address, Address Line Two	1 Electric Street
Entity Address, City or Town	Wan Chai
Entity Address, Country	HK
Entity Address, Postal Zip Code	N/A
Entity Phone Fax Numbers [Line Items]
City Area Code	(+852)
Local Phone Number	9258 9728
Units
Entity Listings [Line Items]
Title of 12(b) Security	Units
Trading Symbol	JVSAU
Security Exchange Name	NASDAQ
Class A ordinary shares, no par value
Entity Listings [Line Items]
Title of 12(b) Security	Class A ordinary shares, no par value
Trading Symbol	JVSA
Security Exchange Name	NASDAQ
Rights
Entity Listings [Line Items]
Title of 12(b) Security	Rights
Trading Symbol	JVSAR
Security Exchange Name	NASDAQ
Class A Ordinary Shares
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		6,248,750
Class B Ordinary Shares
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		1,437,500

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)		Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash		$ 844,690
Prepaid expenses and other current assets		124,887	7,650
Total Current Assets		969,577	7,650
Deferred offering costs			386,725
Investment held in Trust Account		59,579,851
TOTAL ASSETS		60,549,428	394,375
Current liabilities
Accounts payable and accrued expenses		110,755	5,312
Accrued offering costs		70,000	200,000
Total Liabilities		467,140	491,697
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption 5,750,000 shares and 0 shares issued and outstanding at redemption value of $10.14 and $0 at September 30, 2024 and December 31, 2023, respectively		58,294,518
Shareholders’ Equity (Deficit)
Preference shares, no par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital		486,066
Retained earnings (Accumulated deficit)		1,276,704	(122,322)
Total Shareholders’ Equity (Deficit)		1,787,770	(97,322)
TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ EQUITY (DEFICIT)		60,549,428	394,375
Related Party
Current liabilities
Promissory note – related party		286,385	286,385
Class A Ordinary Shares
Shareholders’ Equity (Deficit)
Ordinary shares value
Class B Ordinary Shares
Shareholders’ Equity (Deficit)
Ordinary shares value	[1]	$ 25,000	$ 25,000
[1] Includes up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 23, 2024, Company consummated its IPO and sold 5,750,000 Units, including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 187,500 shares of Class B ordinary shares were no longer subject to forfeiture.

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares		Sep. 30, 2024	Dec. 31, 2023
Preference shares, par value (in Dollars per share)
Preference shares, authorized		1,000,000	1,000,000
Preference shares, issued
Preference shares, outstanding
Class A Ordinary Shares Subject to Possible Redemption
Ordinary shares subject to possible redemption, shares		5,750,000	0
Ordinary shares subject to possible redemption value (in Dollars per share)		$ 10.14	$ 0
Ordinary shares subject to possible redemption, shares outstanding		5,750,000	0
Class A Ordinary Shares
Ordinary shares, par value (in Dollars per share)
Ordinary shares, authorized		100,000,000	100,000,000
Ordinary shares, issued		498,750
Ordinary shares, outstanding		498,750
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)	[1]
Ordinary shares, authorized	[1]	10,000,000	10,000,000
Ordinary shares, issued	[1]	1,437,500	1,437,500
Ordinary shares, outstanding	[1]	1,437,500	1,437,500
[1] Includes up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 23, 2024, Company consummated its IPO and sold 5,750,000 Units, including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 187,500 shares of Class B ordinary shares were no longer subject to forfeiture.

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating and formation costs	$ 149,054	$ 48,928	$ 709,844	$ 50,253
Loss from operations	(149,054)	(48,928)	(709,844)	(50,253)
Other income:
Interest income – Trust	764,667		2,079,851
Interest income – Bank	11,270		29,019
Total other income	775,937		2,108,870
Net income (loss)	$ 626,883	$ (48,928)	$ 1,399,026	$ (50,253)
Class A Ordinary Shares Subject to Redemption
Other income:
Basic weighted average shares outstanding (in Shares)	5,750,000		5,267,336
Diluted weighted average shares outstanding (in Shares)	5,750,000		5,267,336
Basic net income per share (in Dollars per share)	$ 0.16		$ 0.46
Diluted net income per share (in Dollars per share)	$ 0.16		$ 0.46
Non-Redeemable Class A and Class B Ordinary Shares
Other income:
Basic weighted average shares outstanding (in Shares)	1,936,250	1,250,000	1,878,645	1,250,000
Diluted weighted average shares outstanding (in Shares)	1,936,250	1,250,000	1,878,645	1,250,000
Basic net income per share (in Dollars per share)	$ (0.16)	$ (0.04)	$ (0.53)	$ (0.04)
Diluted net income per share (in Dollars per share)	$ (0.16)	$ (0.04)	$ (0.53)	$ (0.04)

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders’ Equity (Deficit) (Unaudited) - USD ($)		Ordinary Shares Class A	Ordinary Shares Class B		Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Total
Balance at Dec. 31, 2022			$ 25,000	[1]		$ (45,495)	$ (20,495)
Balance (in Shares) at Dec. 31, 2022	[1]		1,437,500
Net Income (loss)						(663)	(663)
Balance at Mar. 31, 2023			$ 25,000	[1]		(46,158)	(21,158)
Balance (in Shares) at Mar. 31, 2023	[1]		1,437,500
Balance at Dec. 31, 2022			$ 25,000	[1]		(45,495)	(20,495)
Balance (in Shares) at Dec. 31, 2022	[1]		1,437,500
Net Income (loss)							(50,253)
Balance at Sep. 30, 2023			$ 25,000	[1]		(95,748)	(70,748)
Balance (in Shares) at Sep. 30, 2023	[1]		1,437,500
Balance at Mar. 31, 2023			$ 25,000	[1]		(46,158)	(21,158)
Balance (in Shares) at Mar. 31, 2023	[1]		1,437,500
Net Income (loss)						(662)	(662)
Balance at Jun. 30, 2023			$ 25,000	[1]		(46,820)	(21,820)
Balance (in Shares) at Jun. 30, 2023	[1]		1,437,500
Net Income (loss)						(48,928)	(48,928)
Balance at Sep. 30, 2023			$ 25,000	[1]		(95,748)	(70,748)
Balance (in Shares) at Sep. 30, 2023	[1]		1,437,500
Balance at Dec. 31, 2023			$ 25,000	[1]		(122,322)	(97,322)
Balance (in Shares) at Dec. 31, 2023			1,437,500	[1]
Proceeds allocated to Public Rights, net of issuance costs					2,676,965		2,676,965
Sale of 240,000 Private Placement Units, net of issuance costs of $21,813					2,378,187		2,378,187
Sale of 240,000 Private Placement Units, net of issuance costs of $21,813 (in Shares)		240,000
Issuance of Representative Shares					632,284		632,284
Issuance of Representative Shares (in Shares)		258,750
Accretion of carrying value to redemption value					(1,477,390)		(1,477,390)
Net Income (loss)						330,961	330,961
Balance at Mar. 31, 2024			$ 25,000	[1]	4,210,046	208,639	4,443,685
Balance (in Shares) at Mar. 31, 2024		498,750	1,437,500	[1]
Balance at Dec. 31, 2023			$ 25,000	[1]		(122,322)	(97,322)
Balance (in Shares) at Dec. 31, 2023			1,437,500	[1]
Net Income (loss)							1,399,026
Balance at Sep. 30, 2024			$ 25,000	[1]	486,066	1,276,704	1,787,770
Balance (in Shares) at Sep. 30, 2024		498,750	1,437,500	[1]
Balance at Mar. 31, 2024			$ 25,000	[1]	4,210,046	208,639	4,443,685
Balance (in Shares) at Mar. 31, 2024		498,750	1,437,500	[1]
Accretion of carrying value to redemption value					(1,857,601)		(1,857,601)
Net Income (loss)						441,182	441,182
Balance at Jun. 30, 2024			$ 25,000	[1]	2,352,445	649,821	3,027,266
Balance (in Shares) at Jun. 30, 2024		498,750	1,437,500	[1]
Accretion of carrying value to redemption value					(1,866,379)		(1,866,379)
Net Income (loss)						626,883	626,883
Balance at Sep. 30, 2024			$ 25,000	[1]	$ 486,066	$ 1,276,704	$ 1,787,770
Balance (in Shares) at Sep. 30, 2024		498,750	1,437,500	[1]
[1] Includes up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 23, 2024, Company consummated its IPO and sold 5,750,000 Units, including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 187,500 shares of Class B ordinary shares were no longer subject to forfeiture.

Condensed Statements of Chang_2

Condensed Statements of Changes in Shareholders’ Equity (Deficit) (Unaudited) (Parentheticals)	3 Months Ended
	Mar. 31, 2024 USD ($) shares
Statement of Stockholders' Equity [Abstract]
Net of issuance costs	$ 83,035
Sale of Placement units (in Shares) | shares	240,000
Net of private placement issuance costs	$ 21,813

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities:
Net income (loss)	$ 1,399,026	$ (50,253)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Interest earned on investments held in Trust Account	(2,079,851)
Operating expenses paid by Sponsor from issuance of Promissory Note		50,253
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(117,237)
Accounts payable and accrued expenses	105,443
Net cash used in operating activities	(692,619)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(57,500,000)
Net cash used in investing activities	(57,500,000)
Cash Flows from Financing Activities:
Proceeds from sale of Public Units	57,500,000
Payment of underwriting commissions	(575,000)
Proceeds from sale of Private Placement Units	2,400,000
Payment of offering costs	(287,691)
Net cash provided by financing activities	59,037,309
Net Change in Cash	844,690
Cash – Beginning of period
Cash – End of period	844,690
Non-Cash investing and financing activities:
Re-measurement of carrying value of Class A ordinary shares subject to possible redemption to redemption value	5,201,370
Offering costs included in accrued offering costs	70,000
Representative shares issued and charged to offering costs	$ 632,284

Description of Organization and

Description of Organization and Business Operations	9 Months Ended
	Sep. 30, 2024
Description of Organization and Business Operations [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS JVSPAC Acquisition Corp. (the “Company”) is a blank check company incorporated as a British Virgin Island (“BVI”) business company on April 20, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses (the “Business Combination”). The Company has entered into an Agreement and Plan of Merger with various parties as discussed below. As of September 30, 2024, the Company had not commenced any operations. All activities for the period from April 20, 2021 (inception) through September 30, 2024 relates to the Company’s formation, the initial public offering (the “IPO” or “Initial Public Offering”) described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s IPO was declared effective on January 18, 2024. On January 19, 2024, the underwriters exercised their over-allotment option in full and purchased 750,000 additional Units. On January 23, 2024, the Company consummated its IPO of 5,750,000 units (“Units”), which includes the full exercise of the underwriter’s over-allotment option. Each Unit consists of one Class A ordinary share, no par value per share, and one right to receive of one-fourth of one Class A ordinary share upon the completion of the initial Business Combination. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $57,500,000. Simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of 240,000 units (the “Private Placement Units”) to Winky Investments Limited, the Company’s sponsor (the “Sponsor”), at a price of approximately $10.00 per Private Placement Unit, generating total proceeds of $2,400,000, which is described in Note 4. Transaction costs amounted to $1,715,700 consisting of $575,000 of underwriting commissions which was paid in cash at the closing date of the IPO, $632,284 of the Representative Shares (as defined in Note 6 ), and $544,416 of other offering costs. In conjunction with the IPO, the Company issued to the underwriter 258,750 Class A ordinary shares for no consideration (the “Representative Shares”). The fair value of the Representative Shares accounted for as compensation under Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation” (“ASC 718”) is included in the offering costs. The estimated fair value of the Representative Shares as of the IPO date totaled $632,284. Following the closing of the IPO on January 23, 2024, an amount of $57,500,000 ($10.00 per Unit) from the proceeds of the sale of the Units in the IPO was placed in a trust account (the “Trust Account”). The funds placed in the Trust Account will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the IPO and the private placement will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period (defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity and (iii) the redemption of all of the public shares if the Company is unable to complete the initial Business Combination within the Combination Period (defined below), subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the creditors, if any, which could have priority over the claims of the public shareholders. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a business combination successfully. The initial Business Combination must be with one or more target businesses or assets having an aggregate fair market value of at least 80% of the value of the Trust Account (defined below) (less any taxes payable on interest earned and less any interest earned thereon that is released to the Company for taxes) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under the law or stock exchange listing requirement. The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is initially anticipated to be $10.00 per public share (subject to increase of up to an additional $0.20 per unit in the event that the Sponsor elects to extend the period of time to consummate a Business Combination, as described in more detail in the IPO). The Company accounted for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480). Ordinary shares subject to mandatory redemption (if any) will be classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, ordinary shares will be classified as stockholders’ equity. In accordance with ASC 480-10-S99, the Company classified the Class A ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. Given that the 5,750,000 Class A ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of Class A ordinary shares classified as temporary equity was the allocated proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes in redemption value as a charge against retained earnings or, in the absence of retained earnings, as a charge against additional paid-in-capital over an expected 12-month period leading up to a business combination. The Company will have only 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if the Company extend the period of time to consummate a Business Combination by the full amount of time) (the “Combination Period”) to complete the initial Business Combination. If the Company has not completed the initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under British Virgin Islands law to provide for claims of creditors and the requirements of other applicable law. The underwriters, the Sponsor, officers and directors have agreed to (i) to waive their redemption rights with respect to their Founder Shares (as defined in Note 5), Representative’s Shares (as defined in Note 6) and public shares in connection with the completion of the initial Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Combination Period). If the Company submits the initial Business Combination to the public shareholders for a vote, the underwriters, the Sponsor, officers and directors have agreed (and their permitted transferees will agree), pursuant to the terms of a letter agreement entered into with the Company, to vote any Founder Shares and Representative’s Shares held by them and any public shares purchased during or after the IPO in favor of the initial Business Combination. The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy their indemnity obligations and believes that the Sponsor’s only assets are sec urities of the Company. The Company has not asked the Sponsor to reserve for such obligations. On April 8, 2024, the Company entered into an Agreement and Plan of Merger (the “Original Merger Agreement” and, as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”) with (i) Hotel101 Global Pte. Ltd., a private company limited by shares incorporated under the laws of Singapore (“Hotel101 Global”), (ii) Hotel of Asia, Inc., a company with limited liability incorporated under the laws of the Philippines (“Hotel of Asia” and together with Hotel101 Global, the “Target Parties”), (iii) DoubleDragon Corporation, a company incorporated under the laws of the Philippines and listed on the Philippine Stock Exchange, Inc. (“DoubleDragon”); (iv) DDPC Worldwide Pte. Ltd., a private company limited by shares incorporated under the laws of Singapore and a wholly-owned subsidiary of DoubleDragon (“DDPC”), (v) Hotel101 Worldwide Private Limited, a private company limited by shares incorporated under the laws of Singapore (“Hotel101 Worldwide”, and together with DDPC, and DoubleDragon, the “Principal Shareholders”), (vi) Hotel101 Global Holdings Corp., an exempted company with limited liability incorporated under the laws of the Cayman Islands and a wholly-owned subsidiary of DoubleDragon (“PubCo”), (vii) HGHC 4 Pte. Ltd., a private company limited by shares incorporated under the laws of Singapore and a wholly-owned subsidiary of PubCo (“Merger Sub 1”), and (viii) HGHC 3 Corp., a British Virgin Islands business company and a wholly-owned subsidiary of PubCo (“Merger Sub 2”). Pursuant to the Merger Agreement, among other things, (i) prior to the Company Amalgamation and SPAC Merger (each as defined below), DoubleDragon will transfer 40% of the total issued share capital of Hotel of Asia to PubCo (the “Share Transfer”) in exchange for 30,935,563 PubCo Class A ordinary shares (the “Transfer Payment Shares”) pursuant to a Share Purchase Agreement, (ii) prior to the Company Amalgamation and SPAC Merger (each as defined below), DDPC will transfer to Hotel101 Global certain real estate-related properties free and clear of any encumbrances in exchange for the issuance of ordinary shares in the capital of Hotel101 Global to DDPC (the “Property Transfer”), (iii) Hotel101 Global and Merger Sub 1 will amalgamate, with Hotel101 Global being the surviving entity and becoming a wholly owned subsidiary of PubCo (“Company Amalgamation”) and (iv) the Company will merge with and into Merger Sub 2, with the Company being the surviving entity and becoming a wholly owned subsidiary of PubCo (the “SPAC Merger”). Pursuant to the terms of the Merger Agreement, the aggregate consideration to be paid to DDPC, Hotel 101 Worldwide and certain key executives of the Target Parties is an aggregate of $2,300,000,000 which will be paid entirely in stock, comprised of newly issued ordinary shares of PubCo at a price of $10.00 per share (the “Closing Payment Shares”). The Merger Agreement contains customary representations, warranties and covenants of the parties thereto. The consummation of the proposed Merger See the Current Report on Form 8-K filed by the Company with the SEC on April 8, 2024 for additional information. On September 3, 2024, the Company entered into the First Amendment to Agreement and Plan of Merger (the “First Amendment”) with the Target Parties, the Principal Shareholders, PubCo, Merger Sub 1 and Merger Sub 2, that amended and modified the Original Merger Agreement. Pursuant to the First Amendment, (i) prior to the SPAC Merger and the Company Amalgamation, DoubleDragon will transfer 40% of the total issued share capital of Hotel of Asia to Hotel101 Global, in exchange for the issuance of 1,987,239 Hotel101 Global Shares, (ii) at the Company Amalgamation Effective Time, Hotel101 Global and Merger Sub 1 shall amalgamate and continue as one company, with Hotel101 Global being the surviving entity, and as a wholly owned subsidiary of PubCo, (iii) at the SPAC Merger Effective Time, Merger Sub 2 shall merge with and into the Company with the Company being the surviving entity, and a wholly owned subsidiary of PubCo, (iv) the definitions and provisions of “Closing Payment Shares”, “Consideration Shares”, “Hotel101 Global Shareholder Approval” and “Share Purchase Agreement” were amended, (v) at the Company Amalgamation Effective Time, each of Hotel101 Global Shares issued and outstanding immediately prior to the Company Amalgamation Effective Time shall automatically be cancelled in exchange for the right to receive one PubCo Ordinary Share to be issued on the Closing Date, aggregating to 195,500,000 PubCo Ordinary Shares in total, (vi) certain representations and warranties of the parties and certain covenants regarding D&O Tail Insurance, financial statements, minority shareholder rights, and other matters were amended, (vii) if the Closing is not expected to occur by January 23, 2025 and termination of the Merger Agreement has not occurred, then Hotel101 Global shall deposit into the Company’s working capital account US$2,000,000 to extend the existence and cover certain expenses of the Company, as further described in the First Amendment, (viii) modifications were made to the termination provisions and the Termination Fee was increased to US$2,000,000, and (ix) certain schedules and exhibits to the Original Merger Agreement were amended. See the Current Report on Form 8-K filed by the Company with the SEC on September 5, 2024 for additional information. Going Concern As of September 30, 2024, the Company had cash of $844,690 and a working capital of $502,437. The Sponsor has agreed to loan the Company up to $350,000 to be used for a portion of the expenses of the IPO. The loan is non-interest bearing, unsecured and shall be payable promptly after the date on which the Company consummates an initial public offering of its securities or the date on which the Company determines not to conduct an initial public offering of its securities. As of September 30, 2024, the balance of $286,385 under the promissory note remained unpaid and will be due as demanded. The Company expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. The Company may need to obtain additional financing either to complete its Business Combination or because it becomes obligated to redeem a significant number of public shares upon consummation of its Business Combination, in which case, subject to compliance with applicable securities laws, the Company may issue additional securities or incur debt prior to or in connection with such Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The management’s plan in addressing this uncertainty is through the Working Capital Loans. The Company initially has until January 23, 2025 to consummate the initial Business Combination (assume no extensions). If the Company does not complete a Business Combination, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles of Association. Notwithstanding management’s belief that the Company would have sufficient funds to execute its business strategy, there is a possibility that business combination might not happen within the 12-month period from the date the unaudited condensed financial statements were issued. Management has determined that the mandatory liquidation, should a business combination not occur, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, management believes that it would be prudent to include in its disclosure language about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 23, 2025 (assume no extensions). Risks and Uncertainties As a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 1, 2024. The interim results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has $844,690 and $0 in cash, and no Investment Held in Trust Account At September 30, 2024, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. At December 31, 2023, there were no assets held in the Trust Account. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these trading securities are included in dividends, interest earned, and unrealized gain on investments held in the Trust Account in the accompanying statements of operations and are automatically reinvested therefore are considered as an adjustment to reconcile net income (loss) to net cash used in operating activities in the statements of cash flows. The fair value for these trading securities is determined using available market information. Offering Costs associated with Initial Public Offering Offering costs were $1,751,700 consisting principally of underwriting, legal and other expenses incurred through the balance sheet date that are related to the Public Offering and are charged to shareholders’ equity upon the completion of the Public Offering. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. The Company allocates offering costs among Public Shares, Public Rights and Private Placement Units based on the relative fair values of Public Shares, Public Rights and Private Placement Units. Accordingly, $1,646,852 was allocated to Public Shares and charged to temporary equity, and $104,848 was allocated to Public Rights and Private Placement Units and charged to shareholders’ equity. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares is classified as stockholders’ equity. The Class A ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. In accordance with the SEC and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require ordinary shares subject to redemption to be classified outside of permanent equity. Given that the 5,750,000 Class A ordinary shares sold as part of the Company’s IPO were issued with other freestanding instruments (i.e., Public Units), the initial carrying value of Class A ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. The Company’s Class A ordinary shares is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes in redemption value in additional paid-in capital (or accumulated deficit in the absence of additional paid-in capital) over an expected 12-month period, which is the initial period that the Company has to complete a Business Combination. Accordingly, at September 30, 2024, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of permanent shareholders’ equity (deficit) in the Company’s balance sheets. At September 30, 2024, the Class A Ordinary Shares reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 57,500,000 Less: Proceeds Allocated to Public Rights (2,760,000 ) Allocation of offering costs related to redeemable shares (1,646,852 ) Plus: Accretion of carrying value to redemption value 1,477,390 Class A Ordinary Shares subject to possible redemption, March 31, 2024 $ 54,570,538 Plus: Accretion of carrying value to redemption value 1,857,601 Class A Ordinary Shares subject to possible redemption, June 30, 2024 $ 56,428,139 Plus: Accretion of carrying value to redemption value 1,866,379 Class A Ordinary Shares subject to possible redemption, September 30, 2024 $ 58,294,518 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. ● Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. ● Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. ● Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2024 and December 31, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be a British Virgin Islands business company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The condensed statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. The calculation of diluted income per ordinary share does not consider the effect of the rights issued in connection with the Initial Public Offering and the Private Placement Units since the exercise of the units is contingent upon the occurrence of future events. The rights are exercisable to purchase 1,497,500 Class A Ordinary Shares in the aggregate. The 187,500 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters were not included in the calculation of weighted average shares outstanding until the fully exercise of the over-allotment by the underwriters on January 23, 2024. As of September 30, 2024 and 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares that then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the three months ended For the nine months ended 2024 2023 2024 2023 Net income (loss) $ 626,883 $ (48,928 ) $ 1,399,026 $ (50,253 ) Remeasurement for ordinary shares subject to redemption (1,866,380 ) — (5,201,371 ) — Net loss including accretion of ordinary shares to redemption value $ (1,239,497 ) $ (48,928 ) $ (3,802,345 ) $ (50,253 ) For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Non- Non- Non- Non- Redeemable And Redeemable And Redeemable And Redeemable And Basic net loss per share: Numerator: Net loss $ (927,254 ) $ (312,243 ) $ — $ (48,928 ) $ (2,802,726 ) $ (999,619 ) $ — $ (50,253 ) Remeasurement for ordinary shares subject to redemption 1,866,380 — — — 5,201,371 — — — Allocation of net income (loss) $ 939,126 $ (312,243 ) $ — $ (48,928 ) $ 2,398,645 $ (999,619 ) $ — $ (50,253 ) Denominator: Basic and diluted weighted average shares outstanding 5,750,000 1,936,250 — 1,250,000 5,267,336 1,878,645 — 1,250,000 Basic and diluted net income (loss) per share $ 0.16 $ (0.16 ) $ — (0.04 ) $ 0.46 $ (0.53 ) $ — $ (0.04 ) Recent Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statement.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2024
Initial Public Offering Abstract
INITIAL PUBLIC OFFERING	NOTE 3 — INITIAL PUBLIC OFFERING On January 23, 2024, the Company consummated its Initial Public Offering and sold 5,750,000 Units, including 750,000 Units issued to the underwriter pursuant to the underwriters’ over-allotment option is exercised in full, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share with no par value and one right (the “Public Right”). Each Public Right entitles the holder to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of the Company’s initial Business Combination. The Company will not issue fractional shares upon conversion of the rights, as disclosed in Note 7. Transaction costs amounted to $1,715,700 consisting of $575,000 of underwriting commissions which was paid in cash at the closing date of the IPO, $632,284 of the Representative Shares (As defined in Note 6), and $544,416 of other offering costs.

Private Placement

Private Placement	9 Months Ended
	Sep. 30, 2024
Private Placement Abstract
PRIVATE PLACEMENT	NOTE 4 — PRIVATE PLACEMENT Simultaneously with the closing of the IPO and the over-allotment, the Sponsor purchased an aggregate of 240,000 private placement units at a price of $10.00 per unit for an aggregate purchase price of $2,400,000. Each Private Placement Unit was identical to the units sold in the IPO, except as described below. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Founder Shares, private placement shares or private placement rights. The rights will expire worthless if the Company does not consummate a Business Combination within the allotted 12-month period (or up to 18 months from the completion of the IPO if the Company extends the period of time to consummate a Business Combination by the full amount of time). The private placement units, private placement shares, private placement rights and the Class A ordinary shares underlying such rights will not be transferable, assignable or salable by the Sponsor until the completion of the Company’s initial Business Combination, except to permitted transferees.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 — RELATED PARTY TRANSACTIONS Founder Shares On April 20, 2021, the Company’s Sponsor paid $25,000, or approximately $0.017 per share, to cover certain of the offering and formation costs in exchange for an aggregate of 1,437,500 Class B ordinary shares (the “Founder Shares”) with no par value, 187,500 of which are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised. On January 23, 2024, the underwriters exercised their over-allotment option in full, hence, all 187,500 Founder Shares were no longer subject to forfeiture. Prior to the initial Business Combination, only holders of the Founder Shares will have the right to vote on the election of directors. Holders of the public shares will not be entitled to vote on the election of directors during such time. These provisions of the Company’s amended and restated memorandum and articles of association may only be amended by a resolution passed by holders of at least a majority of the ordinary shares who are eligible to vote and attend and vote in a general meeting of the shareholders. With respect to any other matter submitted to a vote of the shareholders, including any vote in connection with the initial Business Combination, except as required by law, holders of the Founder Shares and holders of the public shares will vote together as a single class, with each share entitling the holder to one vote. The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination or (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the initial Business Combination that results in all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property (the “Lock-up”). Notwithstanding the foregoing, if the last sale price of the Company’s ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day after the initial Business Combination, the Founder Shares will be released from the Lock-up. Promissory Note — Related Party The Sponsor has agreed to loan the Company up to $350,000 to be used for a portion of the expenses of the IPO. The loan is non-interest bearing, unsecured and shall be payable promptly after the date on which the Company consummates an IPO. As of September 30, 2024, the balance of $286,385 under the promissory note remained unpaid and will be due as demanded. Working Capital Loans In addition, in order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,150,000 of such Working Capital Loans may be convertible into units at a price of $10.00 per unit at the option of the lender. Such units would be identical to the Private Placement Units issued to our sponsor. The terms of Working Capital Loans by the Company’s officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2024 and December 31, 2023, the Company had no borrowings under the Working Capital Loans. Directors Compensation The Company has entered into a letter agreement pursuant to which it will also pay each of its independent directors $1,000 per annum, for an aggregate total of $3,000 per annum as remuneration. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these yearly fees. As of September 30, 2024 the Company paid an aggregate of $3,000 for such expenses, which was reported as consulting expense in the accompanying statement of operations. As of September 30, 2023, the Company did not accrue any amount for such expenses. Extension Loan The Company will have until 12 months from the closing of the IPO to consummate an initial Business Combination. However, if the Company anticipates that it may not be able to consummate the initial Business Combination within 12 months, it may extend the period of time to consummate a Business Combination up to two times, each by an additional three months (for a total of up to 18 months to complete a Business Combination). Pursuant to the terms of the amended and restated memorandum and articles of association and the trust agreement entered into between the Company and Continental Stock Transfer & Trust Company on January 18, 2024, in order to extend the time available for the Company to consummate the initial Business Combination, the Sponsor or its affiliates or designees, upon two days advance notice prior to the applicable deadline, must deposit into the Trust Account $500,000, or up to $575,000 if the underwriters’ over-allotment option is exercised in full ($0.10 per share in either case) on or prior to the date of the applicable deadline, for each three month extension (or up to an aggregate of $1,000,000 (or $1,150,000 if the underwriters’ over-allotment option is exercised in full), or $0.20 per share if the Company extends for the full six months). Any such payments would be made in the form of a loan (the “Extension Loans”). Any such loans will be non-interest bearing and payable upon the consummation of the initial Business Combination. If the Company completes the initial Business Combination, it would repay such loaned amounts out of the proceeds of the Trust Account released to the Company. If the Company does not complete a Business Combination, the Company will not repay such loans. Furthermore, the letter agreement with the initial shareholder contains a provision pursuant to which the Sponsor has agreed to waive its right to be repaid for such loans out of the funds held in the Trust Account in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 — COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Units, shares being issued to the underwriters of the IPO, and units that may be issued on conversion of Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable Lock-up period. Notwithstanding the above, the shares issued to the underwriters in the IPO will be further subject to the limitations on registration requirements imposed by FINRA Rule 5110(g)(8). The Company will bear the expenses incurred in connection with the filing of any such registration statements. Right of First Refusal For a period beginning on the closing of the IPO and ending 12 months from the closing of a Business Combination, the Company has granted the underwriter a right of first refusal to act as sole underwriter, sole book-running manager and sole placement agent for any and all future private or public equity, equity-linked, convertible and debt offerings during such 12 months from the closing of a Business Combination of the Company, or any successor to or any subsidiary of the Company. For the sake of clarity, this right of refusal shall encompass the time period leading up to the closing of the Business Combination while the Company is still a special purpose acquisition company. Notwithstanding the foregoing, in event that a target company – in connection with a Business Combination – sources a private placement of public equity (a “PIPE”), the aforementioned right of refusal reference shall not apply in such a limited instance. In accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more than three years from the commencement of sales in the IPO. Underwriter Agreement The underwriter had a 45-day option from the date of the IPO to purchase up to an additional 750,000 Units to cover over-allotments, if any. The underwriter exercised the over - allotment option in fully upon the closing of the IPO. The underwriter was paid $575,000 for the underwriter’s discount, upon the closing of the IPO. Additionally, the underwriter was entitled 258,750 Representative Shares that were registered in the IPO, for no consideration, subject to the terms of the underwriting agreement. The underwriter has agreed not to transfer, assign or sell any such shares until the completion of the initial Business Combination. In addition, the underwriter has agreed (and its permitted transferees will agree) (i) to waive its redemption rights with respect to such shares in connection with the completion of the Company’s initial Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its initial Business Combination within the Combination Period. The shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in the IPO pursuant to FINRA Rule 5110(e)(1). Merger Agreement On April 8, 2024, the Company entered into the Original Merger Agreement with (i) Hotel101 Global, (ii) Hotel of Asia (and together with Hotel101 Global, the “Target Parties”), (iii) DoubleDragon; (iv) DDPC, (v) Hotel101 Worldwide, and together with DDPC, and DoubleDragon, the Principal Shareholders, (vi) PubCo, (vii) Merger Sub 1, and (viii) Merger Sub 2. Pursuant to the Merger Agreement, among other things, (i) prior to the Company Amalgamation and SPAC Merger (each as defined below), DoubleDragon will transfer 40% of the total issued share capital of Hotel of Asia to PubCo in exchange for 30,935,563 PubCo Class A ordinary shares pursuant to a Share Purchase Agreement, (ii) prior to the Company Amalgamation and SPAC Merger (each as defined below), DDPC will transfer to Hotel101 Global certain real estate-related properties free and clear of any encumbrances in exchange for the issuance of ordinary shares in the capital of Hotel101 Global to DDPC, (iii) Hotel101 Global and Merger Sub 1 will amalgamate, with Hotel101 Global being the surviving entity and becoming a wholly owned subsidiary of PubCo and (iv) the Company will merge with and into Merger Sub 2, with the Company being the surviving entity and becoming a wholly owned subsidiary of PubCo. Pursuant to the terms of the Merger Agreement, the aggregate consideration to be paid to DDPC, Hotel 101 Worldwide and certain key executives of the Target Parties is an aggregate of $2,300,000,000 which will be paid entirely in stock, comprised of newly issued ordinary shares of PubCo at a price of $10.00 per share. The Merger Agreement contains customary representations, warranties and covenants of the parties thereto. The consummation of the proposed Merger is subject to certain conditions as further described in the Merger Agreement. See the Current Report on Form 8-K filed by the Company with the SEC on April 8, 2024 for additional information. First Amendment to Merger Agreement On September 3, 2024, the Company entered into the First Amendment with the Target Parties, the Principal Shareholders, PubCo, Merger Sub 1 and Merger Sub 2, that amended and modified the Original Merger Agreement. Pursuant to the First Amendment, (i) prior to the SPAC Merger and the Company Amalgamation, DoubleDragon will transfer 40% of the total issued share capital of Hotel of Asia to Hotel101 Global, in exchange for the issuance of 1,987,239 Hotel101 Global Shares, (ii) at the Company Amalgamation Effective Time, Hotel101 Global and Merger Sub 1 shall amalgamate and continue as one company, with Hotel101 Global being the surviving entity, and as a wholly owned subsidiary of PubCo, (iii) at the SPAC Merger Effective Time, Merger Sub 2 shall merge with and into the Company with the Company being the surviving entity, and a wholly owned subsidiary of PubCo, (iv) the definitions and provisions of “Closing Payment Shares”, “Consideration Shares”, “Hotel101 Global Shareholder Approval” and “Share Purchase Agreement” were amended, (v) at the Company Amalgamation Effective Time, each of Hotel101 Global Shares issued and outstanding immediately prior to the Company Amalgamation Effective Time shall automatically be cancelled in exchange for the right to receive one PubCo Ordinary Share to be issued on the Closing Date, aggregating to 195,500,000 PubCo Ordinary Shares in total, (vi) certain representations and warranties of the parties and certain covenants regarding D&O Tail Insurance, financial statements, minority shareholder rights, and other matters were amended, (vii) if the Closing is not expected to occur by January 23, 2025 and termination of the Merger Agreement has not occurred, then Hotel101 Global shall deposit into the Company’s working capital account US$2,000,000 to extend the existence and cover certain expenses of the Company, as further described in the First Amendment, (viii) modifications were made to the termination provisions and the Termination Fee was increased to US$2,000,000, and (ix) certain schedules and exhibits to the Original Merger Agreement were amended. See the Current Report on Form 8-K filed by the Company with the SEC on September 5, 2024 for additional information.

Shareholder_s Equity (Deficit)

Shareholder’s Equity (Deficit)	9 Months Ended
	Sep. 30, 2024
Shareholder’s Equity (Deficit) [Abstract]
SHAREHOLDER’S EQUITY (DEFICIT)	NOTE 7 — SHAREHOLDER’S EQUITY (DEFICIT) Preferred Shares no no Class A Ordinary Shares no no Class B Ordinary Shares no The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution right, share splits, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein and in the Company’s amended and restated memorandum and articles of association. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the IPO and related to the closing of the initial Business Combination, the ratio at which the Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 20% of the sum of all ordinary shares issued and outstanding upon completion of the IPO, including pursuant to the Over-Allotment Option, plus all Class A ordinary shares issued or deemed issued, or issuable upon the conversion or exercise of any equity-linked securities issued or deemed issued in connection with or in relation to the initial Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination or any private placement-equivalent securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company. Prior to the initial Business Combination, only holders of the Founder Shares will have the right to vote on the election of directors. Holders of the public shares will not be entitled to vote on the election of directors during such time. These provisions of the Company’s amended and restated memorandum and articles of association may only be amended by a resolution passed by holders of at least a majority of the ordinary shares who are eligible to vote and attend and vote in a general meeting of the shareholders. With respect to any other matter submitted to a vote of the shareholders, including any vote in connection with the initial Business Combination, except as required by law, holders of the Founder Shares and holders of the public shares will vote together as a single class, with each share entitling the holder to one vote. Rights If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. As soon as practicable upon the consummation of the initial Business Combination, the Company will direct registered holders of the rights to return their rights to the rights agent. Upon receipt of the rights, the rights agent will issue to the registered holder of such rights the number of full Class A ordinary shares to which it is entitled. The Company will notify registered holders of the rights to deliver their rights to the rights agent promptly upon consummation of such Business Combination and have been informed by the rights agent that the process of exchanging their rights for Class A ordinary shares should take no more than a matter of days. The foregoing exchange of rights is solely ministerial in nature and is not intended to provide the Company with any means of avoiding the Company’s obligation to issue the shares underlying the rights upon consummation of the initial Business Combination. Other than confirming that the rights delivered by a registered holder are valid, the Company will have no ability to avoid delivery of the shares underlying the rights. Nevertheless, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial Business Combination. The shares issuable upon conversion of the rights will be freely tradable (except to the extent held by affiliates of the Company’s). The Company will not issue fractional shares upon conversion of the rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of British Virgin Island’s law. As a result, you must hold rights in multiples of 4 in order to receive shares for all of the investors’ rights upon closing of a Business Combination. If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of an initial Business Combination. Accordingly, the rights may expire worthless.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 8 — FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, Assets: Marketable securities held in Trust Account 1 $ 59,579,851

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 626,883	$ 441,182	$ 330,961	$ (48,928)	$ (662)	$ (663)	$ 1,399,026	$ (50,253)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 1, 2024. The interim results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future periods.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has $844,690 and $0 in cash, and no
Investment Held in Trust Account	Investment Held in Trust Account At September 30, 2024, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. At December 31, 2023, there were no assets held in the Trust Account. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these trading securities are included in dividends, interest earned, and unrealized gain on investments held in the Trust Account in the accompanying statements of operations and are automatically reinvested therefore are considered as an adjustment to reconcile net income (loss) to net cash used in operating activities in the statements of cash flows. The fair value for these trading securities is determined using available market information.
Offering Costs associated with Initial Public Offering	Offering Costs associated with Initial Public Offering Offering costs were $1,751,700 consisting principally of underwriting, legal and other expenses incurred through the balance sheet date that are related to the Public Offering and are charged to shareholders’ equity upon the completion of the Public Offering. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. The Company allocates offering costs among Public Shares, Public Rights and Private Placement Units based on the relative fair values of Public Shares, Public Rights and Private Placement Units. Accordingly, $1,646,852 was allocated to Public Shares and charged to temporary equity, and $104,848 was allocated to Public Rights and Private Placement Units and charged to shareholders’ equity.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares is classified as stockholders’ equity. The Class A ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. In accordance with the SEC and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require ordinary shares subject to redemption to be classified outside of permanent equity. Given that the 5,750,000 Class A ordinary shares sold as part of the Company’s IPO were issued with other freestanding instruments (i.e., Public Units), the initial carrying value of Class A ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. The Company’s Class A ordinary shares is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes in redemption value in additional paid-in capital (or accumulated deficit in the absence of additional paid-in capital) over an expected 12-month period, which is the initial period that the Company has to complete a Business Combination. Accordingly, at September 30, 2024, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of permanent shareholders’ equity (deficit) in the Company’s balance sheets. At September 30, 2024, the Class A Ordinary Shares reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 57,500,000 Less: Proceeds Allocated to Public Rights (2,760,000 ) Allocation of offering costs related to redeemable shares (1,646,852 ) Plus: Accretion of carrying value to redemption value 1,477,390 Class A Ordinary Shares subject to possible redemption, March 31, 2024 $ 54,570,538 Plus: Accretion of carrying value to redemption value 1,857,601 Class A Ordinary Shares subject to possible redemption, June 30, 2024 $ 56,428,139 Plus: Accretion of carrying value to redemption value 1,866,379 Class A Ordinary Shares subject to possible redemption, September 30, 2024 $ 58,294,518
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. ● Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. ● Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. ● Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2024 and December 31, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be a British Virgin Islands business company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The condensed statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. The calculation of diluted income per ordinary share does not consider the effect of the rights issued in connection with the Initial Public Offering and the Private Placement Units since the exercise of the units is contingent upon the occurrence of future events. The rights are exercisable to purchase 1,497,500 Class A Ordinary Shares in the aggregate. The 187,500 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters were not included in the calculation of weighted average shares outstanding until the fully exercise of the over-allotment by the underwriters on January 23, 2024. As of September 30, 2024 and 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares that then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the three months ended For the nine months ended 2024 2023 2024 2023 Net income (loss) $ 626,883 $ (48,928 ) $ 1,399,026 $ (50,253 ) Remeasurement for ordinary shares subject to redemption (1,866,380 ) — (5,201,371 ) — Net loss including accretion of ordinary shares to redemption value $ (1,239,497 ) $ (48,928 ) $ (3,802,345 ) $ (50,253 ) For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Non- Non- Non- Non- Redeemable And Redeemable And Redeemable And Redeemable And Basic net loss per share: Numerator: Net loss $ (927,254 ) $ (312,243 ) $ — $ (48,928 ) $ (2,802,726 ) $ (999,619 ) $ — $ (50,253 ) Remeasurement for ordinary shares subject to redemption 1,866,380 — — — 5,201,371 — — — Allocation of net income (loss) $ 939,126 $ (312,243 ) $ — $ (48,928 ) $ 2,398,645 $ (999,619 ) $ — $ (50,253 ) Denominator: Basic and diluted weighted average shares outstanding 5,750,000 1,936,250 — 1,250,000 5,267,336 1,878,645 — 1,250,000 Basic and diluted net income (loss) per share $ 0.16 $ (0.16 ) $ — (0.04 ) $ 0.46 $ (0.53 ) $ — $ (0.04 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statement.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]
Schedule of Class A Ordinary Shares Reflected in the Balance Sheets	At September 30, 2024, the Class A Ordinary Shares reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 57,500,000 Less: Proceeds Allocated to Public Rights (2,760,000 ) Allocation of offering costs related to redeemable shares (1,646,852 ) Plus: Accretion of carrying value to redemption value 1,477,390 Class A Ordinary Shares subject to possible redemption, March 31, 2024 $ 54,570,538 Plus: Accretion of carrying value to redemption value 1,857,601 Class A Ordinary Shares subject to possible redemption, June 30, 2024 $ 56,428,139 Plus: Accretion of carrying value to redemption value 1,866,379 Class A Ordinary Shares subject to possible redemption, September 30, 2024 $ 58,294,518
Schedule of Basic and Diluted Net Loss Per Ordinary Share	The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the three months ended For the nine months ended 2024 2023 2024 2023 Net income (loss) $ 626,883 $ (48,928 ) $ 1,399,026 $ (50,253 ) Remeasurement for ordinary shares subject to redemption (1,866,380 ) — (5,201,371 ) — Net loss including accretion of ordinary shares to redemption value $ (1,239,497 ) $ (48,928 ) $ (3,802,345 ) $ (50,253 ) For the Three Months Ended For the Nine Months Ended 2024 2023 2024 2023 Non- Non- Non- Non- Redeemable And Redeemable And Redeemable And Redeemable And Basic net loss per share: Numerator: Net loss $ (927,254 ) $ (312,243 ) $ — $ (48,928 ) $ (2,802,726 ) $ (999,619 ) $ — $ (50,253 ) Remeasurement for ordinary shares subject to redemption 1,866,380 — — — 5,201,371 — — — Allocation of net income (loss) $ 939,126 $ (312,243 ) $ — $ (48,928 ) $ 2,398,645 $ (999,619 ) $ — $ (50,253 ) Denominator: Basic and diluted weighted average shares outstanding 5,750,000 1,936,250 — 1,250,000 5,267,336 1,878,645 — 1,250,000 Basic and diluted net income (loss) per share $ 0.16 $ (0.16 ) $ — (0.04 ) $ 0.46 $ (0.53 ) $ — $ (0.04 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Measurements [Abstract]
Schedule of Fair Value Hierarchy of the Valuation Inputs	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, Assets: Marketable securities held in Trust Account 1 $ 59,579,851

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)					3 Months Ended	9 Months Ended
	Sep. 03, 2024	Apr. 08, 2024	Jan. 23, 2024	Jan. 19, 2024	Mar. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Description of Organization and Business Operations [Line Items]
Ordinary price per share (in Dollars per share)						$ 10
Total gross proceeds					$ 57,500,000	$ 57,500,000
Generating total proceeds						2,400,000
Transaction costs						1,715,700
Underwriting commissions paid						575,000
Other offering costs						$ 544,416
Percentage obligation to redeem						100%
Percentage of market value						80%
Percentage of business combination						50%
Interest on trust account can be held to pay dissolution expenses						$ 100,000
Transfer percentage	40%
Exchange of common shares (in Shares)	1,987,239
Aggregating ordinary shares (in Shares)	195,500,000
Working capital account	$ 2,000,000
Termination fee	$ 2,000,000
Cash						844,690
Working capital						502,437
Related Party [Member]
Description of Organization and Business Operations [Line Items]
Due to related party		$ 2,300,000,000
Borrowed						$ 286,385
Sponsor [Member]
Description of Organization and Business Operations [Line Items]
Additional per unit (in Dollars per share)						$ 0.2
Sponsor loan payment						$ 350,000
DoubleDragon [Member]
Description of Organization and Business Operations [Line Items]
Equity ownership percentage		40%
PubCo [Member]
Description of Organization and Business Operations [Line Items]
Ordinary price per share (in Dollars per share)		$ 10
Aggregating ordinary shares (in Shares)	195,500,000
Class A Ordinary Shares [Member]
Description of Organization and Business Operations [Line Items]
Number of shares in a unit (in Shares)			1
Ordinary share, par value (in Dollars per share)
Right to receive share (in Shares)			1
Number of ordinary shares warrant (in Shares)			1
PubCo Class A Ordinary Shares [Member]
Description of Organization and Business Operations [Line Items]
Aggregating ordinary shares (in Shares)		30,935,563
Over-Allotment Option [Member]
Description of Organization and Business Operations [Line Items]
Additional purchase units (in Shares)				750,000
Aggregating ordinary shares (in Shares)						750,000
IPO [Member]
Description of Organization and Business Operations [Line Items]
Number of shares in a unit (in Shares)			1
Number of ordinary shares warrant (in Shares)			1
Ordinary price per share (in Dollars per share)			$ 10
Total gross proceeds			$ 57,500,000			$ 57,500,000
Representative amount						632,284
Estimated fair value						$ 632,284
IPO [Member] | Class A Ordinary Shares [Member]
Description of Organization and Business Operations [Line Items]
Private placement share (in Shares)			5,750,000			5,750,000
Ordinary share, par value (in Dollars per share)			$ 0
Ordinary price per share (in Dollars per share)						$ 10
Representative amount						$ 632,284
Underwriter amount (in Shares)						258,750
Private Placement [Member]
Description of Organization and Business Operations [Line Items]
Private placement share (in Shares)						240,000
Generating total proceeds						$ 2,400,000
Private Placement [Member] | Sponsor [Member]
Description of Organization and Business Operations [Line Items]
Private placement share (in Shares)						240,000
Ordinary price per share (in Dollars per share)						$ 10
Private Placement Unit [Member]
Description of Organization and Business Operations [Line Items]
Generating total proceeds						$ 2,400,000
Public share [Member]
Description of Organization and Business Operations [Line Items]
Ordinary price per share (in Dollars per share)						$ 10

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Summary of Significant Accounting Policies [Line Items]
Cash	$ 844,690	$ 0
Cash, and cash equivalents
Offering costs	1,751,700
Temporary equity charges	1,646,852
Allocated to public rights	104,848
Federal depository insurance coverage	$ 250,000
Class A ordinary Shares Possible Redemption [Member]
Summary of Significant Accounting Policies [Line Items]
Number of shares sold (in Shares)	5,750,000	0
Class A Ordinary Shares [Member]
Summary of Significant Accounting Policies [Line Items]
Stock purchase (in Shares)	1,497,500
Class B Ordinary Shares [Member]
Summary of Significant Accounting Policies [Line Items]
Stock purchase (in Shares)	187,500

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of Class A Ordinary Shares Reflected in the Balance Sheets - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Schedule of Class A Ordinary Shares Reflected in the Balance Sheets [Line Items]
Gross proceeds			$ 57,500,000	$ 57,500,000
Less:
Proceeds Allocated to Public Rights			(2,760,000)
Allocation of offering costs related to redeemable shares			(1,646,852)
Plus:
Accretion of carrying value to redemption value	$ 1,866,379	$ 1,857,601	1,477,390
Class A Ordinary Shares subject to possible redemption	$ 58,294,518	$ 56,428,139	$ 54,570,538	$ 58,294,518

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Ordinary Share - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Schedule of Basic and Diluted Net Loss Per Ordinary Share [Line Items]
Net income (loss)	$ 626,883	$ 441,182	$ 330,961	$ (48,928)	$ (662)	$ (663)	$ 1,399,026	$ (50,253)
Remeasurement for ordinary shares subject to redemption	(1,866,380)						(5,201,371)
Net loss including accretion of ordinary shares to redemption value	(1,239,497)			(48,928)			(3,802,345)	(50,253)
Redeemable Class A [Member]
Schedule of Basic and Diluted Net Loss Per Ordinary Share [Line Items]
Net income (loss)	(927,254)						(2,802,726)
Remeasurement for ordinary shares subject to redemption	1,866,380						5,201,371
Numerator:
Allocation of net income (loss)	$ 939,126						$ 2,398,645
Denominator:
Basic weighted average shares outstanding (in Shares)	5,750,000						5,267,336
Diluted weighted average shares outstanding (in Shares)	5,750,000						5,267,336
Basic net income (loss) per share (in Dollars per share)	$ 0.16						$ 0.46
Diluted net income (loss) per share (in Dollars per share)	$ 0.16						$ 0.46
Non- Redeemable Class A And Class B [Member]
Schedule of Basic and Diluted Net Loss Per Ordinary Share [Line Items]
Net income (loss)	$ (312,243)			$ (48,928)			$ (999,619)	$ (50,253)
Remeasurement for ordinary shares subject to redemption
Numerator:
Allocation of net income (loss)	$ (312,243)			$ (48,928)			$ (999,619)	$ (50,253)
Denominator:
Basic weighted average shares outstanding (in Shares)	1,936,250			1,250,000			1,878,645	1,250,000
Diluted weighted average shares outstanding (in Shares)	1,936,250			1,250,000			1,878,645	1,250,000
Basic net income (loss) per share (in Dollars per share)	$ (0.16)			$ (0.04)			$ (0.53)	$ (0.04)
Diluted net income (loss) per share (in Dollars per share)	$ (0.16)			$ (0.04)			$ (0.53)	$ (0.04)

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)		9 Months Ended
	Jan. 23, 2024	Sep. 30, 2024
Initial Public Offering [Line Items]
Transaction costs (in Dollars)		$ 1,715,700
Underwriting commissions paid (in Dollars)		575,000
Other offering costs (in Dollars)		544,416
IPO [Member]
Initial Public Offering [Line Items]
Number of units issued	5,750,000
Price per unit (in Dollars per share)	$ 10
Number of shares in a unit	1
Number of right warrant	1
Number of ordinary shares warrant	1
Representative shares (in Dollars)		$ 632,284
Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Number of units issued	750,000

Private Placement (Details)

Private Placement (Details) - Private Placement [Member]	9 Months Ended
	Sep. 30, 2024 USD ($) $ / shares shares
Private Placement [Line Items]
Aggregate shares | shares	240,000
Unit price per shares | $ / shares	$ 10
Aggregate purchase price | $	$ 2,400,000

Related Party Transactions (Det

Related Party Transactions (Details)				3 Months Ended	9 Months Ended
	Jan. 23, 2024 shares	Jan. 18, 2024 USD ($) $ / shares	Apr. 20, 2021 USD ($) $ / shares shares	Mar. 31, 2024 USD ($)	Sep. 30, 2024 USD ($) $ / shares
Related Party Transactions [Line Items]
Sponsor paid				$ 2,378,187
Offering price per share (in Dollars per share) | $ / shares					$ 10
Working capital loans					$ 1,150,000
Aggregate directors compensation					$ 3,000
IPO closing period					12 months
Extend period					12 months
Complete business combination period					18 months
Over-allotment option is exercised (in Dollars per share) | $ / shares		$ 0.1
Promissory Note-Related Party [Member]
Related Party Transactions [Line Items]
Borrowed					$ 286,385
Convertible price per unit (in Dollars per share) | $ / shares					$ 10
Sponsor [Member]
Related Party Transactions [Line Items]
Sponsor loan					$ 350,000
Founder Shares [Member]
Related Party Transactions [Line Items]
Voteing rights					one
Exceeds price per share (in Dollars per share) | $ / shares					$ 12
Minimum number of trading days					20
Common stock threshold consecutive trading days					30
Extension Loan [Member]
Related Party Transactions [Line Items]
Offering price per share (in Dollars per share) | $ / shares		$ 0.2
Trust account		$ 500,000
Option exercised		575,000
Aggregate amount		1,000,000
Director [Member]
Related Party Transactions [Line Items]
Independent directors fees					$ 1,000
Aggregate remunerations					$ 3,000
Class B Ordinary Shares [Member]
Related Party Transactions [Line Items]
Voteing rights					one
Class B Ordinary Shares [Member] | Founder Shares [Member] | Sponsor [Member]
Related Party Transactions [Line Items]
Sponsor paid			$ 25,000
Aggregate ordinary shares (in Shares) | shares			1,437,500
Over-Allotment Option [Member]
Related Party Transactions [Line Items]
Subject to forfeiture (in Shares) | shares			187,500
Over-Allotment Option [Member] | Founder Shares [Member]
Related Party Transactions [Line Items]
Subject to forfeiture (in Shares) | shares	187,500
Over-Allotment Option [Member] | Extension Loan [Member]
Related Party Transactions [Line Items]
Aggregate amount		$ 1,150,000
Over-Allotment Option [Member] | Class B Ordinary Shares [Member] | Sponsor [Member]
Related Party Transactions [Line Items]
Offering price per share (in Dollars per share) | $ / shares			$ 0.017
Over-Allotment Option [Member] | Class B Ordinary Shares [Member] | Founder Shares [Member]
Related Party Transactions [Line Items]
Offering price per share (in Dollars per share) | $ / shares			$ 0.017

Commitments and Contingencies (

Commitments and Contingencies (Details)			9 Months Ended
	Sep. 03, 2024 USD ($) shares	Apr. 08, 2024 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) shares
Commitments and Contingencies [Line Items]
Maximum number of demands for registration of securities			3
Deemed compensation lock up period			180 days
Percentage of total issued share capital transferred	40%
Exchange of common shares	1,987,239
Aggregating ordinary shares	195,500,000
Working Capital Account (in Dollars) | $	$ 2,000,000
Termination fee (in Dollars) | $	$ 2,000,000
PubCo [Member]
Commitments and Contingencies [Line Items]
Percentage of total issued share capital transferred		40%
Aggregate consideration (in Dollars) | $		$ 2,300,000,000
Price of per share (in Dollars per share) | $ / shares		$ 10
Class A Ordinary Shares [Member] | PubCo [Member]
Commitments and Contingencies [Line Items]
Exchange of common shares		30,935,563
Over-Allotment Option [Member]
Commitments and Contingencies [Line Items]
Underwriters days			45 days
Additional purchase of units			750,000
IPO [Member]
Commitments and Contingencies [Line Items]
Underwriter's discount (in Dollars) | $			$ 575,000
Issuance of representative shares			258,750

Shareholder_s Equity (Deficit)

Shareholder’s Equity (Deficit) (Details) - USD ($)						9 Months Ended
		Sep. 30, 2024		Jan. 23, 2024	Apr. 20, 2021	Sep. 30, 2024		Dec. 31, 2023
Shareholder’s Equity [Line Items]
Preferred shares, authorized		1,000,000				1,000,000		1,000,000
Preferred shares, per value (in Dollars per share)
Preferred stock, shares issued
Preferred stock, shares outstanding
Founder shares (in Dollars per share)		$ 10				$ 10
Class A Ordinary Shares [Member]
Shareholder’s Equity [Line Items]
Ordinary shares, shares authorized		100,000,000				100,000,000		100,000,000
Ordinary shares, par value (in Dollars per share)
Ordinary shares, shares outstanding		498,750				498,750
Ordinary shares, shares issued		498,750				498,750
Class A Ordinary Shares Subject To Possible Redemption [Member]
Shareholder’s Equity [Line Items]
Subject to possible redemption		5,750,000				5,750,000		0
Class B Ordinary Shares [Member]
Shareholder’s Equity [Line Items]
Ordinary shares, shares authorized	[1]	10,000,000				10,000,000		10,000,000
Ordinary shares, par value (in Dollars per share)	[1]
Ordinary shares, shares outstanding		1,437,500	[1]		1,437,500	1,437,500	[1]	1,437,500	[1]
Ordinary shares, shares issued	[1]	1,437,500				1,437,500		1,437,500
Subject of forfeiture (in Dollars)					$ 187,500
Aggregate forfeiture				187,500
Aggregate percentage						20%
Description of voting shares						one
Rights [Member]
Shareholder’s Equity [Line Items]
Rights outstanding shares		5,990,000				5,990,000
Over-Allotment Option [Member] | Class B Ordinary Shares [Member] | Sponsor [Member]
Shareholder’s Equity [Line Items]
Sponsor paid (in Dollars)					$ 25,000
Founder shares (in Dollars per share)					$ 0.017
IPO [Member]
Shareholder’s Equity [Line Items]
Sponsor paid (in Dollars)						$ 632,284
Founder shares (in Dollars per share)				$ 10
Number of ordinary share		1
IPO [Member] | Class A Ordinary Shares [Member]
Shareholder’s Equity [Line Items]
Ordinary shares, par value (in Dollars per share)				$ 0
Sponsor paid (in Dollars)						$ 632,284
Founder shares (in Dollars per share)		$ 10				$ 10
[1] Includes up to 187,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 23, 2024, Company consummated its IPO and sold 5,750,000 Units, including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 187,500 shares of Class B ordinary shares were no longer subject to forfeiture.

Fair Value Measurements (Detai

Fair Value Measurements (Details) - Schedule of Fair Value Hierarchy of the Valuation Inputs	Sep. 30, 2024 USD ($)
Fair Value, Recurring [Member] | Level 1 [Member]
Assets:
Marketable securities held in Trust Account	$ 59,579,851